Acyclovir Suspension
Product Images NDC 17856-2170

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Acyclovir Suspension (NDC 17856-2170). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Atlantic Biologicals Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (17856 2170 01 Rev. 1 Case Label)

1 (17856 2170 01 Rev. 1 Case Label)
This text appears to be detailing information about Acyclovir UDOSE oral suspension in 200mg/5mL dosage. It includes details on preservatives composition, storage instructions, dosage guidelines, and package contents. The product is presented in cups and has a dosage of 200mg/5mL. It is recommended to refer to the package insert for indications and dosage schedules.*
FDA Label Image

2 (17856 2170 02 Rev. 1 Case Label)

2 (17856 2170 02 Rev. 1 Case Label)
This is a description of Acyclovir UDOSE Oral Suspension, USP, providing 400mg/10mL. Each 5mL contains Acyclovir 200mg and preservatives methylparaben 0.1% and Propylparaben 0.02%. The dosage is 400mg/10mL. The product comes in a package of 72 cups with a GTIN of 0317856217026. For reordering, contact 800.509.7592.*
FDA Label Image

Acyclo-os-structure.jpg (Acyclo Os Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.